VC/A  Eshelman Ventures

http://www.eshelmanventures.com/





     Office Locations:

319 N. 3rd Street, Suite 301
Wilmington, NC 28401
Phone: 910-558-6885

 

Stages:

  • Early
  • Growth
  • Middle Market


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Eshelman Ventures is an investment company primarily interested in healthcare companies. The firm was founded by Fred Eshelman, who previously founded and served as CEO and Executive Chairman of Pharmaceutical Product Development (PPDI, NASDAQ) prior to the sale of the company to private equity interests. Although Eshelman Ventures concentrates in healthcare, the firm will consider other themes that are attractive and have large potential markets.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Fred Eshelman Founder

     

    Portfolio companies include:


      Asepticys
        web link


      Carbon3D
        web link


      Cellective BioTherapy
        web link


      Dignify Therapeutics
        web link


      Eyenovia
        web link


      G1 Therapeutics
        web link


      Innocrin Pharmaceutical
        web link


      Innocrin Pharmaceuticals
        web link


      Medikidz
        web link


      Neoantigenics
        web link


      The Medicines Company
        web link


     

    Recent News: